# RACE IT (NCT03529890)

> Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder

No report yet. It can be ordered.

- Drugs tested: nivolumab plus radiation therapy
- Indication: locally advanced urothelial carcinoma of the bladder

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03529890
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Technical University of Munich
- Conditions: Urinary Bladder Cancer
- Interventions: Nivolumab; Radiation therapy of the pelvis; Radical cystectomy with standardized pelvic lymphadenectomy
- Enrollment: 33
- Primary outcome: Rate of patients with completed Treatment

## Indexed commentary on RACE IT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 6

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=race-it-nct03529890